Sihuan placement slammed as stock drops 10%
The stock of Sihuan Pharmaceutical holdings group fell 10.4% the day after two selling shareholders raised HK$1.8bn ($236m) through a sell-down of their holdings in the company on Monday, with bankers away from the deal blaming pricing.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts